SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-010082
Filing Date
2021-01-15
Accepted
2021-01-15 16:12:31
Documents
15
Period of Report
2021-01-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d111083d8k.htm   iXBRL 8-K 26976
2 EX-5.1 d111083dex51.htm EX-5.1 42788
6 GRAPHIC g111083img1.jpg GRAPHIC 13956
7 GRAPHIC g111083img2.jpg GRAPHIC 6909
  Complete submission text file 0001193125-21-010082.txt   225473

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crsp-20210115.xsd EX-101.SCH 3069
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20210115_lab.xml EX-101.LAB 17305
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20210115_pre.xml EX-101.PRE 10928
8 EXTRACTED XBRL INSTANCE DOCUMENT d111083d8k_htm.xml XML 3272
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 21532249
SIC: 2836 Biological Products, (No Diagnostic Substances)